Primary ependymoma of the ovary, in which long-term oral etoposide (VP-16) was effective in prolonging disease-free survival

Mikio Mikami, Yuuki Komuro, Naoko Sakaiya, Chisei Tei, Takashi Kurahashi, Shinichi Komiyama, Takanori Hirose

研究成果: Article

15 引用 (Scopus)

抄録

Background. Ovarian ependymoma is an extremely unusual teratoma of the ovary with only eight cases previously reported in the literature worldwide. Case. A 26-year-old woman presented in 1992 with a sensation of abdominal fullness. The laparotomy revealed ovarian cancer (stage III), which proved to be an ependymoma pathologically. Three courses of the PVP regimen (cisplatin, vinblastine, peplomycin) and pelvic irradiation were administered postoperatively. Oral administration of etoposide (VP-16) was initiated after the residual tumor began to proliferate, and the tumor decreased in size and never regrew during etoposide administration for a total of 5 years and 8 months. The recurrent tumor was observed soon after the drug was discontinued. Conclusion. Oral administration of etoposide was effective in prolonging disease-free survival.

元の言語English
ページ(範囲)149-152
ページ数4
ジャーナルGynecologic Oncology
83
発行部数1
DOI
出版物ステータスPublished - 2001
外部発表Yes

Fingerprint

Ependymoma
Etoposide
Disease-Free Survival
Ovary
Oral Administration
Peplomycin
Vinblastine
Teratoma
Residual Neoplasm
Ovarian Neoplasms
Laparotomy
Cisplatin
Neoplasms
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology

これを引用

Primary ependymoma of the ovary, in which long-term oral etoposide (VP-16) was effective in prolonging disease-free survival. / Mikami, Mikio; Komuro, Yuuki; Sakaiya, Naoko; Tei, Chisei; Kurahashi, Takashi; Komiyama, Shinichi; Hirose, Takanori.

:: Gynecologic Oncology, 巻 83, 番号 1, 2001, p. 149-152.

研究成果: Article

Mikami, M, Komuro, Y, Sakaiya, N, Tei, C, Kurahashi, T, Komiyama, S & Hirose, T 2001, 'Primary ependymoma of the ovary, in which long-term oral etoposide (VP-16) was effective in prolonging disease-free survival', Gynecologic Oncology, 巻. 83, 番号 1, pp. 149-152. https://doi.org/10.1006/gyno.2001.6343
Mikami, Mikio ; Komuro, Yuuki ; Sakaiya, Naoko ; Tei, Chisei ; Kurahashi, Takashi ; Komiyama, Shinichi ; Hirose, Takanori. / Primary ependymoma of the ovary, in which long-term oral etoposide (VP-16) was effective in prolonging disease-free survival. :: Gynecologic Oncology. 2001 ; 巻 83, 番号 1. pp. 149-152.
@article{878a1c741a9c463abc62f28a9b19c05c,
title = "Primary ependymoma of the ovary, in which long-term oral etoposide (VP-16) was effective in prolonging disease-free survival",
abstract = "Background. Ovarian ependymoma is an extremely unusual teratoma of the ovary with only eight cases previously reported in the literature worldwide. Case. A 26-year-old woman presented in 1992 with a sensation of abdominal fullness. The laparotomy revealed ovarian cancer (stage III), which proved to be an ependymoma pathologically. Three courses of the PVP regimen (cisplatin, vinblastine, peplomycin) and pelvic irradiation were administered postoperatively. Oral administration of etoposide (VP-16) was initiated after the residual tumor began to proliferate, and the tumor decreased in size and never regrew during etoposide administration for a total of 5 years and 8 months. The recurrent tumor was observed soon after the drug was discontinued. Conclusion. Oral administration of etoposide was effective in prolonging disease-free survival.",
keywords = "Ependymoma, Etoposide, Ovarian neoplasma, VP-16",
author = "Mikio Mikami and Yuuki Komuro and Naoko Sakaiya and Chisei Tei and Takashi Kurahashi and Shinichi Komiyama and Takanori Hirose",
year = "2001",
doi = "10.1006/gyno.2001.6343",
language = "English",
volume = "83",
pages = "149--152",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Primary ependymoma of the ovary, in which long-term oral etoposide (VP-16) was effective in prolonging disease-free survival

AU - Mikami, Mikio

AU - Komuro, Yuuki

AU - Sakaiya, Naoko

AU - Tei, Chisei

AU - Kurahashi, Takashi

AU - Komiyama, Shinichi

AU - Hirose, Takanori

PY - 2001

Y1 - 2001

N2 - Background. Ovarian ependymoma is an extremely unusual teratoma of the ovary with only eight cases previously reported in the literature worldwide. Case. A 26-year-old woman presented in 1992 with a sensation of abdominal fullness. The laparotomy revealed ovarian cancer (stage III), which proved to be an ependymoma pathologically. Three courses of the PVP regimen (cisplatin, vinblastine, peplomycin) and pelvic irradiation were administered postoperatively. Oral administration of etoposide (VP-16) was initiated after the residual tumor began to proliferate, and the tumor decreased in size and never regrew during etoposide administration for a total of 5 years and 8 months. The recurrent tumor was observed soon after the drug was discontinued. Conclusion. Oral administration of etoposide was effective in prolonging disease-free survival.

AB - Background. Ovarian ependymoma is an extremely unusual teratoma of the ovary with only eight cases previously reported in the literature worldwide. Case. A 26-year-old woman presented in 1992 with a sensation of abdominal fullness. The laparotomy revealed ovarian cancer (stage III), which proved to be an ependymoma pathologically. Three courses of the PVP regimen (cisplatin, vinblastine, peplomycin) and pelvic irradiation were administered postoperatively. Oral administration of etoposide (VP-16) was initiated after the residual tumor began to proliferate, and the tumor decreased in size and never regrew during etoposide administration for a total of 5 years and 8 months. The recurrent tumor was observed soon after the drug was discontinued. Conclusion. Oral administration of etoposide was effective in prolonging disease-free survival.

KW - Ependymoma

KW - Etoposide

KW - Ovarian neoplasma

KW - VP-16

UR - http://www.scopus.com/inward/record.url?scp=0034791119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034791119&partnerID=8YFLogxK

U2 - 10.1006/gyno.2001.6343

DO - 10.1006/gyno.2001.6343

M3 - Article

C2 - 11585429

AN - SCOPUS:0034791119

VL - 83

SP - 149

EP - 152

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -